Ad
related to: is cabotegravir approved for prep for colonoscopy- Read PrEP FAQs
Find Common Questions Regarding
PrEP On This Official HCP Site
- PrEP Expert Insights
View Our Peer Insights Page With
Videos And Info On PrEP For HCPs
- PrEP Prescribing Options
Read About Prescribing Options And
Discuss With Your Patients Today
- See The Impact of PrEP
See How PrEP Has Impacted HIV Rates
,Statistics And The Community
- Read PrEP FAQs
Search results
Results from the WOW.Com Content Network
Cabotegravir in combination with rilpivirine is indicated for the treatment of human immunodeficiency virus type-1 (HIV-1) in adults. [1] [7] The combination injection is intended for maintenance treatment of adults who have undetectable HIV levels in the blood (viral load less than 50 copies/mL) with their current antiretroviral treatment, and when the virus has not developed resistance to ...
[4] [8] [9] It is the first FDA-approved injectable, complete regimen for HIV-infected adults that is administered once a month. [4] [5] It is also approved for use in Canada. [1] In the European Union, the two medications are approved separately and have different brand names: Vocabria (for cabotegravir) and Rekambys (for rilpivirine). [10 ...
In 2012, the FDA approved the drug for use as pre-exposure prophylaxis (PrEP), based on growing evidence that the drug was safe and effective at preventing HIV in populations at increased risk of infection. [41] The FDA has approved two additional medications for PrEP since then, approving Descovy in 2019 and Cabotegravir (Apretude) in 2021. [4 ...
A colonoscopy is typically performed under sedation. During that time, a gastroenterologist will insert a colonoscope, which is a flexible tube with a camera at the end, into the rectum, and will ...
The study seeks to test injectable PrEP as a way to remedy adherence for many patients on a daily pill regimen. [3] HPTN 083 is the first large scale phase III clinical trial of cabotegravir. [4] In February 2016 researchers presented the results of the ECLAIR study. [5] That study examined cabotegravir and found no serious safety concerns. [5]
Rilpivirine, sold under the brand names Edurant and Rekambys, is a medication, developed by Tibotec, used for the treatment of HIV/AIDS. [5] [6] It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs such as efavirenz.
New research suggests patients with an average risk of colon cancer may only need to undergo a colonoscopy screening every 15 years instead of the recommended 10.. Swedish researchers found that ...
Kevin Costner is returning to Yellowstone in a new way. His new docuseries, 'Yellowstone to Yosemite,' premieres on February 8 on Fox Nation.
Ad
related to: is cabotegravir approved for prep for colonoscopy